| Date | Time | Source | Announcement |
|---|---|---|---|
| 19 May 2011 | 05:20 PM | Holding(s) in Company | |
| 19 Apr 2011 | 12:32 PM | Holding(s) in Company | |
| 19 Apr 2011 | 12:28 PM | Holding(s) in Company | |
| 08 Apr 2011 | 09:20 AM | Holding(s) in Company | |
| 05 Apr 2011 | 02:34 PM | Director/PDMR Shareholding | |
| 04 Apr 2011 | 12:41 PM | Holding(s) in Company | |
| 04 Apr 2011 | 09:35 AM | Holding(s) in Company | |
| 29 Mar 2011 | 07:00 AM | Director/PDMR Shareholding | |
| 29 Mar 2011 | 07:00 AM | Interim Results | |
| 28 Mar 2011 | 09:47 AM | Holding(s) in Company | |
| 17 Mar 2011 | 09:23 AM | Re Agreement - Replacement | |
| 17 Mar 2011 | 07:20 AM | Re Agreement | |
| 28 Feb 2011 | 01:22 PM | Interim Results Announcement | |
| 18 Feb 2011 | 04:26 PM | Holding(s) in Company | |
| 05 Jan 2011 | 11:41 AM | Directors' Shareholdings and | |
| 20 Dec 2010 | 11:36 AM | Adviser - Change of Name | |
| 26 Nov 2010 | 03:48 PM | AGM results | |
| 03 Nov 2010 | 07:00 AM | Commercial Update | |
| 05 Oct 2010 | 07:00 AM | Final Results | |
| 04 Oct 2010 | 12:07 PM | Director/PDMR Shareholding | |
| 10 Aug 2010 | 11:12 AM | Holding(s) in Company | |
| 29 Jul 2010 | 07:00 AM | Pre close statement | |
| 23 Jul 2010 | 01:50 PM | Holding(s) in Company | |
| 02 Jul 2010 | 10:53 AM | Director/PDMR Shareholding | |
| 30 Apr 2010 | 09:42 AM | Holding(s) in Company | |
| 01 Apr 2010 | 07:00 AM | Director's Shareholding Updat | |
| 09 Mar 2010 | 07:00 AM | Change of Adviser | |
| 09 Mar 2010 | 07:00 AM | Half Yearly Report | |
| 24 Feb 2010 | 09:55 AM | Half Yearly Report | |
| 04 Jan 2010 | 01:43 PM | Director/PDMR Shareholding | |
| 09 Dec 2009 | 05:09 PM | Holding(s) in Company | |
| 02 Dec 2009 | 07:00 AM | Result of AGM | |
| 01 Dec 2009 | 05:34 PM | Holding(s) in Company | |
| 01 Dec 2009 | 05:33 PM | Holding(s) in Company | |
| 01 Dec 2009 | 11:11 AM | Holding(s) in Company | |
| 30 Nov 2009 | 02:50 PM | Holding(s) in Company | |
| 20 Nov 2009 | 08:31 AM | Cash Placing | |
| 04 Nov 2009 | 02:38 PM | Posting of Annual Report and | |
| 23 Oct 2009 | 09:57 AM | Holding(s) in Company | |
| 21 Oct 2009 | 04:58 PM | Holding(s) in Company | |
| 16 Oct 2009 | 03:41 PM | Holding(s) in Company | |
| 12 Oct 2009 | 03:10 PM | Director/PDMR Shareholding | |
| 06 Oct 2009 | 07:30 AM | Final Results | |
| 01 Oct 2009 | 07:00 AM | Director/PDMR Shareholding | |
| 18 Sep 2009 | 09:08 AM | Notice of Preliminary Results | |
| 18 Aug 2009 | 03:29 PM | Additional Listing | |
| 30 Jul 2009 | 07:30 AM | Pre-Close Trading Update | |
| 13 Jul 2009 | 10:46 AM | Holding(s) in Company | |
| 13 Jul 2009 | 10:10 AM | Director/PDMR Shareholding | |
| 10 Jun 2009 | 09:50 AM | Holding(s) in Company |
Genedrive plc is a medical equipment company based in Manchester, UK that develops and sells point-of-care molecular diagnostic platforms. Their products are used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. Genedrive's goal is to improve clinical outcomes with easy-to-use tests.
Genedrive's major products include:
Genedrive CYP2C19 ID Kit: A rapid test that establishes metaboliser status in time-critical settings
Genedrive MT-RNR1 ID Kit: The world's first point-of-care genetic test to reduce the risk of aminoglycoside induced hearing loss
Genedrive was founded on contract research services for pharmaceutical and biotech companies, and was originally named Epistem Holdings Inc. when it was floated on the London AIM market in 2007. The company was renamed genedrive plc in 2016 to reflect its new focus on molecular diagnostics, and divested its contract research services divisions in 2018.
GDR share price launched at 129p in 2007.